Biotech And The Broad Market

Published 03/01/2017, 11:57 AM
Updated 07/09/2023, 06:31 AM
US500
-
XBI
-

During the last 5 years, what sector has doubled the S&P 500's performance? And how is it doing lately?

Below looks at the Biotech ETF XBI since 2012. The chart shows that over the past 5 years, the S&P 500 has done very well -- it's up 70%. During the same time frame, XBI is up 160%, gaining more than 100% more than the broad markets.

SPDR S&P Biotech

Biotech looks to have influenced the broad markets, as it declined from the summer of 2015 until Feb. 2016 along with the S&P 500. When Biotech turned higher 1 year ago, the broad market followed suit, although the broad market has lagged this leading sector since the lows.

Currently, XBI is working on a breakout of a year-long pennant pattern to the upside. If history continues to repeat, what this leading sector does going forward will have a big influence on the broad markets. Risk-on stock trade wants to see XBI clear the highs of late 2015 (where the top of the pennant pattern started). This level comes into play as a resistance test.

Full Disclosure: Premium Members are long XBI at this time, with a stop near the top of the pennant pattern.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.